ARVINAS, INC. Increase (Decrease) in Accounts Receivable
ARVINAS, INC. (ARVN) reported Increase (Decrease) in Accounts Receivable of $49.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- ARVINAS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $48.50M, a 48400.00% increase year-over-year.
- ARVINAS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $800.00K.
- ARVINAS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$19.30M.
- ARVINAS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $19.80M, a 171.23% increase year-over-year.
- ARVINAS, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$4.70M, a 182.46% decline from fiscal 2024.
- ARVINAS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $5.70M.
- ARVINAS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$1.00M.
- ARVINAS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$14.00M, a 200.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $49.30M 10-Q · filed 2026-08-04 | $30.00M derived: sum of 3 quarters · filed 2026-08-04 | $49.80M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $800.00K 10-Q · filed 2026-05-11 | -$18.50M derived: sum of 2 quarters · filed 2026-05-11 | $1.30M derived: sum of 3 quarters · filed 2026-05-11 | $1.40M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | -$19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $500.00K derived: sum of 2 quarters · filed 2026-02-24 | $600.00K derived: sum of 3 quarters · filed 2026-08-04 | -$4.70M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $19.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $19.90M derived: sum of 2 quarters · filed 2026-08-04 | $14.60M 10-Q · filed 2025-11-05 | $13.00M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$5.20M 10-Q · filed 2026-08-04 | -$6.80M derived: sum of 3 quarters · filed 2026-08-04 | $500.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | -$5.30M 10-Q · filed 2026-05-11 | -$6.90M derived: sum of 2 quarters · filed 2026-05-11 | $400.00K derived: sum of 3 quarters · filed 2026-05-11 | $400.00K derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.70M derived: sum of 2 quarters · filed 2026-02-24 | $5.70M derived: sum of 3 quarters · filed 2026-02-24 | $5.70M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.30M derived: sum of 2 quarters · filed 2025-11-05 | $7.30M 10-Q · filed 2025-11-05 | -$8.40M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | -$15.70M derived: sum of 3 quarters · filed 2026-02-24 | -$100.00K derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | -$15.70M derived: sum of 2 quarters · filed 2026-02-24 | -$100.00K derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | -$15.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$100.00K derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | -$1.00M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $15.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $15.70M derived: sum of 2 quarters · filed 2024-10-30 | $14.70M 10-Q · filed 2024-10-30 | $14.70M derived: sum of 4 quarters · filed 2025-02-11 | ||
| 2023-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$900.00K 10-Q · filed 2024-07-30 | -$900.00K derived: sum of 3 quarters · filed 2025-02-11 | -$1.30M derived: sum of 4 quarters · filed 2025-02-11 | ||
| 2023-03-31 | -$1.00M 10-Q · filed 2024-05-07 | -$1.00M derived: sum of 2 quarters · filed 2025-02-11 | -$1.40M derived: sum of 3 quarters · filed 2025-02-11 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$400.00K derived: sum of 2 quarters · filed 2025-02-11 | $1.00M derived: sum of 3 quarters · filed 2025-02-11 | -$14.00M 10-K · filed 2025-02-11 | ||
| 2022-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.00M derived: sum of 2 quarters · filed 2023-11-07 | -$14.00M 10-Q · filed 2023-11-07 | -$900.00K derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$13.60M 10-Q · filed 2023-08-08 | -$500.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.40M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | -$15.00M 10-Q · filed 2023-05-05 | -$1.90M derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $15.00M derived: sum of 2 quarters · filed 2024-02-27 | $15.00M derived: sum of 3 quarters · filed 2024-02-27 | $14.00M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.90M derived: sum of 2 quarters · filed 2022-11-09 | $900.00K 10-Q · filed 2022-11-09 | $880.18K 10-Q · filed 2021-11-03 | -$544.45K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.00M 10-Q · filed 2022-08-04 | -$2.44M derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | -$1.00M 10-Q · filed 2022-05-05 | -$2.44M derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.00M derived: sum of 2 quarters · filed 2023-02-23 | $1.00M derived: sum of 3 quarters · filed 2023-02-23 | $1.00M 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.44M derived: sum of 2 quarters · filed 2021-11-03 | $2.44M 10-Q · filed 2021-11-03 | $2.36M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | -$83.50K derived: sum of 3 quarters · filed 2022-02-28 | -$24.17K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | -$83.50K derived: sum of 2 quarters · filed 2022-02-28 | -$24.17K derived: sum of 3 quarters · filed 2022-02-28 | -$24.17K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | -$83.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$24.17K derived: sum of 2 quarters · filed 2022-02-28 | -$24.17K derived: sum of 3 quarters · filed 2022-02-28 | -$2.80M 10-K · filed 2022-02-28 | -$2.78M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $59.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $59.33K derived: sum of 2 quarters · filed 2020-11-05 | -$2.72M 10-Q · filed 2020-11-05 | $59.33K derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$2.78M 10-Q · filed 2020-08-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$2.78M 10-Q · filed 2020-04-28 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.78M derived: sum of 2 quarters · filed 2021-03-01 | $2.78M derived: sum of 3 quarters · filed 2021-03-01 | -$22.22M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | -$25.00M 10-Q · filed 2019-11-04 | $0.00 derived: sum of 4 quarters · filed 2019-11-04 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$25.00M 10-Q · filed 2019-08-05 | $0.00 derived: sum of 3 quarters · filed 2019-08-05 | |||
| 2018-03-31 | -$25.00M 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $25.00M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |